U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 01:44:05 GMT 2025
Edited
by admin
on Wed Apr 02 01:44:05 GMT 2025
Protein Type MONOCLONAL ANTIBODY CONJUGATE
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
VF40YVX65F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BA-3011
Preferred Name English
MECBOTAMAB VEDOTIN
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BA301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA301 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO
Common Name English
MECBOTAMAB VEDOTIN [USAN]
Common Name English
Mecbotamab vedotin [WHO-DD]
Common Name English
mecbotamab vedotin [INN]
Common Name English
BA3011
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 659718
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
FDA ORPHAN DRUG 802920
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
Code System Code Type Description
INN
11946
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
SMS_ID
300000039973
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
CAS
2460400-64-8
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
NCI_THESAURUS
C156141
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
USAN
JK-82
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
FDA UNII
VF40YVX65F
Created by admin on Wed Apr 02 01:44:05 GMT 2025 , Edited by admin on Wed Apr 02 01:44:05 GMT 2025
PRIMARY
From To
1_22 1_96
1_147 1_203
1_223 3_214
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
2_22 2_96
2_147 2_203
2_223 4_214
2_264 2_324
2_370 2_428
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
CONJUGATE COMPONENT->CONJUGATE
TARGET->LIGAND
CONJUGATE COMPONENT->CONJUGATE
Related Record Type Details
METABOLITE ACTIVE -> PARENT
ASSUMED FROM BRENTUXIMAB VEDOTIN RECORD
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION RESIDUE_SPECIFIC C Amount: Cysteinyl vedotin 6603L01WUR
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL